# Agios Pharmaceuticals, Inc.: Form 8-K, filed Jun 14, 2023

- Company: [Agios Pharmaceuticals, Inc.](/companies/agio.md) (CIK 1439222)
- Form: 8-K
- Filed: 2023-06-14
- Accepted by EDGAR: Jun 14, 2023, 16:05 ET
- Period: 2023-06-13
- Accession: 0001193125-23-166855
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/d415331d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/d415331d8k.htm

Filed Jun 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-166855. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
